CytomX Therapeutics Inc (CTMX)
1.62
+0.03
(+1.89%)
USD |
NASDAQ |
Apr 29, 14:59
CytomX Therapeutics Shares Outstanding: 67.72M for Feb. 29, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 29, 2024 | 67.72M |
December 31, 2023 | 67.31M |
October 31, 2023 | 66.99M |
September 30, 2023 | 66.87M |
August 11, 2023 | 66.77M |
July 31, 2023 | 66.77M |
July 28, 2023 | 66.77M |
June 30, 2023 | 66.77M |
April 30, 2023 | 66.34M |
April 17, 2023 | 66.34M |
March 31, 2023 | 66.34M |
February 28, 2023 | 66.23M |
December 31, 2022 | 66.23M |
October 31, 2022 | 66.08M |
September 30, 2022 | 65.95M |
July 29, 2022 | 65.95M |
June 30, 2022 | 65.76M |
April 29, 2022 | 65.40M |
April 18, 2022 | 65.40M |
March 31, 2022 | 65.40M |
January 31, 2022 | 65.39M |
December 31, 2021 | 65.39M |
October 31, 2021 | 65.25M |
September 30, 2021 | 65.25M |
July 31, 2021 | 65.16M |
Date | Value |
---|---|
June 30, 2021 | 65.16M |
April 30, 2021 | 65.01M |
April 19, 2021 | 65.00M |
March 31, 2021 | 65.00M |
February 02, 2021 | 64.78M |
January 25, 2021 | 62.54M |
December 31, 2020 | 48.25M |
October 31, 2020 | 46.22M |
September 30, 2020 | 46.22M |
July 31, 2020 | 46.19M |
June 30, 2020 | 46.19M |
April 30, 2020 | 45.92M |
April 20, 2020 | 45.92M |
March 31, 2020 | 45.92M |
January 31, 2020 | 45.57M |
December 31, 2019 | 45.52M |
October 31, 2019 | 45.43M |
September 30, 2019 | 45.43M |
July 31, 2019 | 45.41M |
June 30, 2019 | 45.40M |
April 30, 2019 | 45.31M |
April 22, 2019 | 45.31M |
April 02, 2019 | 45.26M |
March 31, 2019 | 45.16M |
January 31, 2019 | 45.11M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
45.31M
Minimum
Apr 30 2019
67.72M
Maximum
Feb 29 2024
59.35M
Average
65.25M
Median
Sep 30 2021
Shares Outstanding Benchmarks
Ocular Therapeutix Inc | 148.63M |
Bristol-Myers Squibb Co | 2.027B |
ACADIA Pharmaceuticals Inc | 164.77M |
Cytokinetics Inc | 103.00M |
Calidi Biotherapeutics Inc | 35.54M |